Cambrex Corporation (CBM) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE MEADOWLANDS PLZ
E RUTHERFORD, NJ 07073
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments59,38367,53995,85297,135171,348187,568
Cash and cash equivalents59,38367,53995,85297,135171,348187,568
Receivables117,33390,055151,52886,406115,64177,032
Inventory, net of allowances, customer advances and progress billings109,586119,530111,062103,64899,562104,544
Inventory109,586119,530111,062103,64899,562104,544
Other undisclosed current assets114,51095,90151,650129,621117,67293,597
Total current assets:400,812373,025410,092416,810504,223462,741
Noncurrent Assets
Property, plant and equipment402,202398,774360,528352,947266,075270,378
Intangible assets, net (including goodwill)660,755664,016448,300463,38355,61757,814
Goodwill408,013407,512261,095271,42442,86444,372
Intangible assets, net (excluding goodwill)252,742256,504187,205191,95912,75313,442
Other noncurrent assets5,5355,7363,0993,1923,5323,465
Other undisclosed noncurrent assets46,45347,2391,40911,5571,4481,822
Total noncurrent assets:1,114,9451,115,765813,336831,079326,672333,479
TOTAL ASSETS:1,515,7571,488,7901,223,4281,247,889830,895796,220
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities95,07197,91792,69981,51088,28885,032
Taxes payable6,9094,4501,6512,7273,3888,162
Accounts payable38,84750,71747,01238,20551,59643,932
Accrued liabilities49,31542,75044,03640,57833,30432,938
Debt10,00010,000    
Contract with customer, liability56,14515,22711,71310,2698,153 
Other undisclosed current liabilities2,9372,709   6,721
Total current liabilities:164,153125,853104,41291,77996,44191,753
Noncurrent Liabilities
Liabilities, other than long-term debt146,179181,452165,289171,832111,12772,730
Contract with customer, liability4,72443,05242,70143,37939,000 
Deferred tax liabilities, net76,71572,97157,27666,2319,3777,129
Liability, pension and other postretirement and postemployment benefits41,30541,37342,21838,42938,44440,633
Other liabilities23,43524,05623,09423,79324,30624,968
Other undisclosed noncurrent liabilities528,840522,158300,000325,000 39,000
Total noncurrent liabilities:675,019703,610465,289496,832111,127111,730
Total liabilities:839,172829,463569,701588,611207,568203,483
Equity
Equity, attributable to parent676,585659,327653,727659,278623,327592,737
Common stock3,4923,4923,4873,4813,4483,438
Treasury stock, value(10,777)(10,777)(10,777)(10,860)(10,860)(12,140)
Additional paid in capital186,078184,410182,691181,435172,480170,340
Accumulated other comprehensive loss(66,698)(66,670)(60,137)(52,029)(52,263)(39,004)
Retained earnings564,490548,872538,463537,251510,522470,103
Total equity:676,585659,327653,727659,278623,327592,737
TOTAL LIABILITIES AND EQUITY:1,515,7571,488,7901,223,4281,247,889830,895796,220

Income Statement (P&L) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Revenues176,850159,456134,332104,618152,046141,097
Revenue, net141,097
Cost of revenue
(Cost of Goods and Services Sold)
(114,022)(104,573)(86,016)(71,893)(87,254)(90,242)
Gross profit:62,82854,88348,31632,72564,79250,855
Operating expenses(29,935)(34,559)(28,485)(26,093)(20,140)(20,474)
Operating income:32,89320,32419,8316,63244,65230,381
Nonoperating expense(353)(72)(193)(109)(181)(264)
Gain, foreign currency transaction, before tax  562    
Income from continuing operations before equity method investments, income taxes:32,54020,25219,6386,52344,47130,117
Other undisclosed income (loss) from continuing operations before income taxes(8,981)(6,193)(877)4,8865,129(82)
Income from continuing operations before income taxes:23,55914,05918,76111,40949,60030,035
Income tax expense (benefit)(7,872)(3,532)(17,468)15,406(8,748)(5,786)
Income from continuing operations:15,68710,5271,29326,81540,85224,249
Income before gain (loss) on sale of properties:15,61810,4091,21226,72940,41924,058
Income (loss) from discontinued operations(69)(118)(81)(86)(433)(191)
Net income available to common stockholders, diluted:15,61810,4091,21226,72940,41924,058

Comprehensive Income ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net income:15,61810,4091,21226,72940,41924,058
Other comprehensive income (loss)(28)(6,533)(18,612)202206295
Comprehensive income (loss):15,5903,876(17,400)26,93140,62524,353
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   10,50432(13,465)2,929
Comprehensive income (loss), net of tax, attributable to parent:15,5903,876(6,896)26,96327,16027,282

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: